// App-Quantinova.ai

2798 : Enhanced HIF1 inhibition through dual inhibition of CDK and HSP90

Researchers

Presenter

  • Shuai Zhao

Principal Investigators

  • David T. Dicker

  • Wafik S. El-Deiry

Medical Centers

  • Fox Chase Cancer Center, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Glioblastoma

  • Solid malignancies

Biomarkers

  • Cyclin-dependent kinase 4

  • Hypoxia-inducible factor-1

Drug/Treatment

  • Geldanamycin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved